ANDREW CHEN: Open Payments
NPI 1174029565 · SHREWSBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 7 payments from 6 companies in 2025. Trend: 2023 $261 · 2024 $83 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
Products named: UZEDY, INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY, VIVITROL.
Industry payments across NJ — which companies pay providers there.
